CGBioMedix Selected for Global Healthcare Project
The company will conduct training sessions for spine specialists in Australia as part of a government initiative.
Updated on Sept. 22, 2026 in Healthcare
Live Poll
Do you believe specialized medical device training for clinicians improves local patient care?
CGBioMedix has been selected for the 2026 Biohealth Global Expansion Support Project promoted by South Korean authorities. The firm will use this opportunity to host a hands-on training workshop for international medical professionals.
Why it matters
This initiative aims to ensure that overseas medical staff fully understand the operation and application of specialized implants in clinical settings. Such training is intended to facilitate the adoption of the company's orthopedic and dental devices by foreign medical institutions.
Approximately 40 spine specialists from across Asia are scheduled to participate in the upcoming cadaver workshop. This training is designed to build technical proficiency with proprietary medical hardware.
The players
CGBioMedix
This is a medical company that specializes in the development and manufacturing of orthopedic and dental implants.
Ministry of Health and Welfare
This is a South Korean government body responsible for the oversight of public health policies and the promotion of the nation's healthcare industry.
Korea Health Industry Development Institute
This is an agency under the South Korean government that works to enhance the competitiveness of the domestic healthcare and biotech industries.
University of Melbourne
This is an Australian public research university that will host the upcoming medical training workshop.
The details
During the hands-on curriculum, participants will operate the L'DISQ device, which uses radiofrequency plasma energy to remove disc lesions, and the EXPEDIO device, which utilizes a balloon catheter for targeted medication delivery. The company will also collect user feedback and consult with local distribution partners to assess the viability of device adoption.
Timeline
CGBioMedix received its selection for the project on September 22, 2026.
The cadaver training workshop is scheduled to take place in October 2026.
Market Landscape
This move represents a strategic effort by South Korean medical device manufacturers to capture larger market shares in the competitive Asian healthcare sector. By prioritizing hands-on training, the company aims to reduce barriers to clinical adoption compared to international competitors.
The initiative may lead to increased availability of advanced spinal treatment options within hospitals across Asia. Patients in these regions could see improved clinical outcomes as local surgeons gain direct experience with new radiofrequency and catheter-based devices.
The takeaway
Hands-on training remains a critical component for the successful integration of specialized medical technology into international clinical practice. Manufacturers that prioritize surgeon proficiency often see higher rates of device adoption and improved long-term market trust.
What happens next
CGBioMedix is scheduled to conduct a cadaver workshop for spine specialists at the University of Melbourne in October 2026.
Further reading
For broader trends in medical device education and industry development, see our Healthcare section.
Source note: This article includes information reported by Business Korea.
Live Poll
Do you believe specialized medical device training for clinicians improves local patient care?
